# A Study of LY2951742 in Participants With Migraine

> **NCT01625988** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 218 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** LY2951742
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01625988
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-28
- **Primary completion:** 2013-07
- **Final completion:** 2013-09-18
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625988, "A Study of LY2951742 in Participants With Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01625988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*